Stem Cell Integral Membrane Transporter ABCB5 and Dermal Regeneration

NIH RePORTER · NIH · P01 · $538,988 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Project 3 will test the central hypotheses that (1) ABCB5(+) dermal mesenchymal stem cells (DMSC) are required for normal adult skin homeostasis and regeneration; (2) ABCB5(+) DMSC decline is responsible for impaired skin homeostasis and regenerative wound healing during aging; and (3) ABCB5(+) DMSC transplantation possesses therapeutic potential to restore age-related impairment of skin homeostasis and regeneration. The overall significance of this study are the potential shifts in research paradigms resulting from successful completion of this research: (1) The proposed experiments will answer a fundamental question in stem cell biology and aging that has not been addressed as-of-yet in prospective studies – To what extent is selective dysfunction in an adult stem cell compartment (vis-à-vis dysregulation of differentiated tissues) responsible for organismal aging?; and (2) Documentation of the regenerative capacity of ABCB5(+) DMSC along with demonstration of their decline as a cause age-related impairment of skin regenerative capacity will lay the foundation for targeted employment of this candidate cell therapeutic for the treatment of cutaneous wounds in aging patients.

Key facts

NIH application ID
10884378
Project number
5P01AG071463-03
Recipient
BRIGHAM AND WOMEN'S HOSPITAL
Principal Investigator
Markus H. Frank
Activity code
P01
Funding institute
NIH
Fiscal year
2024
Award amount
$538,988
Award type
5
Project period
2022-09-30 → 2027-05-31